News Archive

Displaying the 10 most recent press releases...

Friday, March 21, 2014
EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results
Monday, January 13, 2014
EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
Thursday, November 14, 2013
EntreMed Reports Third Quarter 2013 Financial Results
Thursday, October 31, 2013
EntreMed Commences Phase 2 Trial For ENMD-2076 In Ovarian Clear Cell Carcinomas
Tuesday, October 22, 2013
Data Presented For ENMD-2076 In Xenograft Models Of Human Hepatocellular Carcinoma
Monday, October 21, 2013
Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
Wednesday, August 14, 2013
EntreMed Reports Second Quarter 2013 Financial Results
Monday, July 29, 2013
EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
Thursday, June 27, 2013
EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA To Expand Clinical Trial For Advanced/Metastatic Sarcoma
Wednesday, May 15, 2013
EntreMed Reports First Quarter 2013 Financial Results